Scinovex
review Open AccessTop 1% cited

Coronavirus Disease 2019 (COVID-19): A Perspective from China

Radiology · 2020 · Vol. 296(2) · pp. E15–E25
Ziyue ZuMeng JiangPeng XuWen ChenQian NiGuangming LuLong Jiang Zhang

Abstract

In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 infection occurred in Wuhan, Hubei Province, China, and spread across China and beyond. On February 12, 2020, the World Health Organization officially named the disease caused by the novel coronavirus as coronavirus disease 2019 (COVID-19). Because most patients infected with COVID-19 had pneumonia and characteristic CT imaging patterns, radiologic examinations have become vital in early diagnosis and the assessment of disease course. To date, CT findings have been recommended as major evidence for clinical diagnosis of COVID-19 in Hubei, China. This review focuses on the etiology, epidemiology, and clinical symptoms of COVID-19 while highlighting the role of chest CT in prevention and disease control.

COVID-19 diagnosis using AICOVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsMedicineCoronavirus disease 2019 (COVID-19)PneumoniaCoronavirusOutbreakDiseaseEpidemiologyChinaEtiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

MeSH terms

BetacoronavirusCOVID-19SARS-CoV-2COVID-19 TestingChinaDiagnosis, DifferentialHumansPneumonia, ViralSeverity of Illness IndexTomography, X-Ray ComputedCoronavirus InfectionsClinical Laboratory TechniquesEarly DiagnosisPandemics

Funding

  • National Key Research and Development Program of China
  • National Key Research and Development Program of China Stem Cell and Translational Research
Citations
2,139
FWCI
224.01
field-weighted impact
References
60
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.